In the Phase IIb trial data summarized by Metabolic Pharmaceuticals, participants receiving up to 1 mg/day of oral AOD-9604 for 24 weeks showed no statistically significant changes in fasting glucose, insulin, or IGF-1 compared to placebo [6]
Journal of Nutritional Biochemistry 1 (5): 228237
Benzyl alcohol at 0.9% works by disrupting bacterial cell membranes and denaturing proteins, which inhibits microbial growth without necessarily killing the organisms outright
Preferred subcutaneous sites include the abdomen and the outer upper arms, providing straightforward access for individuals administering their own injections: Abdomen: Injections are given at least two inches away from the navel, allowing for a broad area of fat tissue
Telemedicine-Only Experience Your entire program is delivered remotely: Virtual evaluations Online follow-ups Doorstep medication delivery Rapid provider access Zero waiting rooms, zero hassle Perfect for busy professionals, frequent travelers, or anyone wanting discreet concierge care